Starting from a simple saliva sample, the partner laboratories in our network generate raw genomic data using high-precision molecular analysis technologies.
Depending on the level of analysis required, we use:
▪ Illumina™ GSA Microarray
Analysis of more than 900,000 selected genetic variants using high-density microarray technology.
▪ NGS Sequencing (Next Generation Sequencing)
WES (Whole Exome Sequencing):
analysis of all ~22,000 protein-coding genes
WGS (Whole Genome Sequencing):
analysis of the entire human genome
Illumina™ massively parallel sequencing technology enables accurate and scalable reading
of the human genome.
These technologies are widely used in genomic research and clinical genomics worldwide.
Through proprietary bioinformatics pipelines and
AI-driven systems, we transform raw genomic data
into actionable, scientifically validated insights.
We have developed proprietary technologies
and intellectual property to ensure:
▪ high-quality genomic analysis
▪ continuous updates of scientific evidence
▪ full process traceability
▪ robust data protection
Our artificial intelligence technology integrates:
▪ hundreds of peer-reviewed scientific studies
▪ international genomic databases
▪ aggregated and validated datasets
and enables us to:
▪ correlate genetic variants with phenotypes
▪ generate personalized and dynamic reports
▪ update interpretations as new scientific
evidence emerges
▪ support professionals and users in a clear and accessible way
We do not simply provide data.
We transform the genome into actionable knowledge.
We operate in compliance with the highest standards
of quality, cybersecurity and personal data protection, ensuring:
▪ secure infrastructures
▪ management in compliance with applicable regulations
▪ continuous updates of methodologies
Science is our foundation.
Innovation is our tool.